 | • レポートコード：D005-00698 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、感染症検査における分子診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。感染症検査における分子診断の種類別市場規模（ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他）、用途別市場規模（病院、クリニック、学術機関、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Luminex、Thermo Fisher Scientific、BD、Veridex、BioMerieux、Qiagen、Siemens、Roche、GenMark Diagnostics、Genomix Biotech、BioTheranostics ・地域別グローバル市場分析 2015年-2020年 ・感染症検査における分子診断の北米市場（アメリカ、カナダ、メキシコ） ・感染症検査における分子診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・感染症検査における分子診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・感染症検査における分子診断の南米市場（ブラジル、アルゼンチン） ・感染症検査における分子診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、マイクロアレイ、次世代シーケンシング（NGS）、ハイブリダイゼーション、その他 ・用途別分析：病院、クリニック、学術機関、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Molecular Diagnostics in Infectious Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Molecular Diagnostics in Infectious Disease Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Molecular Diagnostics in Infectious Disease Testing market has been segmented into:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
By Application, Molecular Diagnostics in Infectious Disease Testing has been segmented into:
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Molecular Diagnostics in Infectious Disease Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Molecular Diagnostics in Infectious Disease Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Molecular Diagnostics in Infectious Disease Testing market.
The report offers in-depth assessment of the growth and other aspects of the Molecular Diagnostics in Infectious Disease Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Molecular Diagnostics in Infectious Disease Testing Market Share Analysis
Molecular Diagnostics in Infectious Disease Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Molecular Diagnostics in Infectious Disease Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Molecular Diagnostics in Infectious Disease Testing sales, revenue and market share for each player covered in this report.
The major players covered in Molecular Diagnostics in Infectious Disease Testing are:
Abbott
Luminex
Thermo Fisher Scientific
BD
Veridex
BioMerieux
Qiagen
Siemens
Roche
GenMark Diagnostics
Genomix Biotech
BioTheranostics
Table of Contents
1 Molecular Diagnostics in Infectious Disease Testing Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics in Infectious Disease Testing
1.2 Classification of Molecular Diagnostics in Infectious Disease Testing by Type
1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type in 2019
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.5 Microarrays
1.2.6 Next-Generation Sequencing (NGS)
1.2.7 Hybridization
1.2.8 Others
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market by Application
1.3.1 Overview: Global Molecular Diagnostics in Infectious Disease Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic Institutes
1.3.5 Laboratories
1.3.6 Others
1.4 Global Molecular Diagnostics in Infectious Disease Testing Market by Regions
1.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Molecular Diagnostics in Infectious Disease Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics in Infectious Disease Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Luminex
2.2.1 Luminex Details
2.2.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Luminex SWOT Analysis
2.2.4 Luminex Product and Services
2.2.5 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Thermo Fisher Scientific SWOT Analysis
2.3.4 Thermo Fisher Scientific Product and Services
2.3.5 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BD SWOT Analysis
2.4.4 BD Product and Services
2.4.5 BD Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Veridex
2.5.1 Veridex Details
2.5.2 Veridex Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Veridex SWOT Analysis
2.5.4 Veridex Product and Services
2.5.5 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioMerieux
2.6.1 BioMerieux Details
2.6.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioMerieux SWOT Analysis
2.6.4 BioMerieux Product and Services
2.6.5 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Qiagen SWOT Analysis
2.7.4 Qiagen Product and Services
2.7.5 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Siemens
2.8.1 Siemens Details
2.8.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Siemens SWOT Analysis
2.8.4 Siemens Product and Services
2.8.5 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 GenMark Diagnostics
2.10.1 GenMark Diagnostics Details
2.10.2 GenMark Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GenMark Diagnostics SWOT Analysis
2.10.4 GenMark Diagnostics Product and Services
2.10.5 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Genomix Biotech
2.11.1 Genomix Biotech Details
2.11.2 Genomix Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Genomix Biotech SWOT Analysis
2.11.4 Genomix Biotech Product and Services
2.11.5 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 BioTheranostics
2.12.1 BioTheranostics Details
2.12.2 BioTheranostics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 BioTheranostics SWOT Analysis
2.12.4 BioTheranostics Product and Services
2.12.5 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Diagnostics in Infectious Disease Testing Players Market Share
3.2.2 Top 10 Molecular Diagnostics in Infectious Disease Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Regions
4.2 North America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
4.5 South America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
5 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
5.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
5.2 USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
6 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
6.1 Europe Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
6.2 Germany Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
6.3 UK Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
6.4 France Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
7.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
7.2 China Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
7.5 India Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
8 South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries
8.1 South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
8.2 Brazil Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Molecular Diagnostics in Infectious Disease Testing by Countries
9.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Type (2019-2024)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)
10.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Growth Rate (2015-2025)
10.5 Microarrays Revenue Growth Rate (2015-2025)
10.6 Next-Generation Sequencing (NGS) Revenue Growth Rate (2015-2025)
10.7 Hybridization Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Molecular Diagnostics in Infectious Disease Testing Market Segment by Application
11.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2015-2020)
11.2 Molecular Diagnostics in Infectious Disease Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Academic Institutes Revenue Growth (2015-2020)
11.6 Laboratories Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast (2021-2025)
12.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast (2021-2025)
12.2 Global Molecular Diagnostics in Infectious Disease Testing Market Forecast by Regions (2021-2025)
12.3 North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
12.4 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
12.6 South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Molecular Diagnostics in Infectious Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Molecular Diagnostics in Infectious Disease Testing Major Business
Table 7. Abbott Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 10. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Luminex Corporate Information, Location and Competitors
Table 12. Luminex Molecular Diagnostics in Infectious Disease Testing Major Business
Table 13. Luminex Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2018-2019)
Table 14. Luminex SWOT Analysis
Table 15. Luminex Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 16. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 18. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Major Business
Table 19. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 20. Thermo Fisher Scientific SWOT Analysis
Table 21. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 22. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BD Corporate Information, Location and Competitors
Table 24. BD Molecular Diagnostics in Infectious Disease Testing Major Business
Table 25. BD Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 26. BD SWOT Analysis
Table 27. BD Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 28. BD Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Veridex Corporate Information, Location and Competitors
Table 30. Veridex Molecular Diagnostics in Infectious Disease Testing Major Business
Table 31. Veridex Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 32. Veridex SWOT Analysis
Table 33. Veridex Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 34. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BioMerieux Corporate Information, Location and Competitors
Table 36. BioMerieux Molecular Diagnostics in Infectious Disease Testing Major Business
Table 37. BioMerieux Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 38. BioMerieux SWOT Analysis
Table 39. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 40. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Qiagen Corporate Information, Location and Competitors
Table 42. Qiagen Molecular Diagnostics in Infectious Disease Testing Major Business
Table 43. Qiagen Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 44. Qiagen SWOT Analysis
Table 45. Qiagen Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 46. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Siemens Corporate Information, Location and Competitors
Table 48. Siemens Molecular Diagnostics in Infectious Disease Testing Major Business
Table 49. Siemens Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 50. Siemens SWOT Analysis
Table 51. Siemens Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 52. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Molecular Diagnostics in Infectious Disease Testing Major Business
Table 55. Roche Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 58. Roche Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GenMark Diagnostics Corporate Information, Location and Competitors
Table 60. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Major Business
Table 61. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 62. GenMark Diagnostics SWOT Analysis
Table 63. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 64. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Genomix Biotech Corporate Information, Location and Competitors
Table 66. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Major Business
Table 67. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 68. Genomix Biotech SWOT Analysis
Table 69. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 70. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. BioTheranostics Corporate Information, Location and Competitors
Table 72. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Major Business
Table 73. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Total Revenue (USD Million) (2017-2018)
Table 74. BioTheranostics SWOT Analysis
Table 75. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product and Solutions
Table 76. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Players (2015-2020)
Table 78. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players (2015-2020)
Table 79. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Regions (2015-2020)
Table 81. North America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
Table 82. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Table 83. Europe Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Molecular Diagnostics in Infectious Disease Testing Revenue by Countries (2015-2020)
Table 86. South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Table 89. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) by Type (2015-2020)
Table 90. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type (2015-2020)
Table 91. Global Molecular Diagnostics in Infectious Disease Testing Revenue Forecast by Type (2021-2025)
Table 92. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Application (2015-2020)
Table 93. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application (2015-2020)
Table 94. Global Molecular Diagnostics in Infectious Disease Testing Revenue Forecast by Application (2021-2025)
Table 95. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Molecular Diagnostics in Infectious Disease Testing Picture
Figure 2. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type in 2019
Figure 3. Polymerase Chain Reaction (PCR) Picture
Figure 4. Isothermal Nucleic Acid Amplification Technology (INAAT) Picture
Figure 5. Microarrays Picture
Figure 6. Next-Generation Sequencing (NGS) Picture
Figure 7. Hybridization Picture
Figure 8. Others Picture
Figure 9. Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Academic Institutes Picture
Figure 13. Laboratories Picture
Figure 14. Others Picture
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Molecular Diagnostics in Infectious Disease Testing Revenue Market Share in 2019
Figure 24. Global Top 10 Players Molecular Diagnostics in Infectious Disease Testing Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Regions (2015-2020)
Figure 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Regions in 2018
Figure 29. North America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 30. Europe Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 32. South America Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 34. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 35. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2019
Figure 36. USA Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 37. Canada Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 39. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2019
Figure 41. Germany Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 42. UK Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 43. France Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 44. Russia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 45. Italy Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2019
Figure 48. China Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 49. Japan Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 50. Korea Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 51. India Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 53. South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 54. South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2019
Figure 55. Brazil Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 60. UAE Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Molecular Diagnostics in Infectious Disease Testing Revenue and Growth Rate (2015-2020)
Figure 63. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type (2015-2020)
Figure 64. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Type in 2019
Figure 65. Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Type (2021-2025)
Figure 66. Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2020)
Figure 67. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Growth Rate (2015-2020)
Figure 68. Global Microarrays Revenue Growth Rate (2015-2020)
Figure 69. Global Next-Generation Sequencing (NGS) Revenue Growth Rate (2015-2020)
Figure 70. Global Hybridization Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application (2015-2020)
Figure 73. Global Molecular Diagnostics in Infectious Disease Testing Revenue Share by Application in 2019
Figure 74. Global Molecular Diagnostics in Infectious Disease Testing Market Share Forecast by Application (2021-2025)
Figure 75. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 76. Global Clinics Revenue Growth Rate (2015-2020)
Figure 77. Global Academic Institutes Revenue Growth Rate (2015-2020)
Figure 78. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Molecular Diagnostics in Infectious Disease Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
Figure 84. Europe Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
Figure 86. South America Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
ポイントオブケア感染症診断/検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 mill…- 感染症用POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 23730 million by 2025, from USD 20400 million in 2019. The Point of Care Te…
- 腸疾患検査＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Enteric Disease Testing and Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3273.4 million by 2025, from USD 3101.6 million in 2019. …
- 女性健康診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Women Health Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Women Health Diagnos…